Nathan S. Smith

Nathan has technical experience managing IP for a variety of technologies, with a focus on the life sciences and technology industries, and is a co-leader of the IP MedTech Working Group. He has handled matters involving medical devices, pharmaceuticals, and therapies related to eye care, medical aesthetics, cardiology, heart valve replacement, neurovascular disorders, orthopedics, dental implants, spinal fixation, gastroenterology, and women’s health.  Nate also has technical experience managing IP for various other clients in areas including eyewear, personal electronics, oil and gas, software, automotive, agriculture and grain management, and aeronautics.

Nathan also strives to balance his practice by devoting himself to pro bono work. He has personally represented victims of domestic violence and their families in obtaining nonimmigrant status, assisted a foundation that provides therapy to children whose families are unable to afford treatment for autism spectrum disorder, assisted a foundation that cares for mothers of children with disabilities and survivors of grief and trauma, and assisted a foundation that provides therapeutic activity for individuals diagnosed with cystic fibrosis.

Nathan has authored various articles and hosted a podcast related to developments in IP in the United States and globally. Additionally, he has spoken at events and on panels on topics involving international IP filing strategies, IP portfolio management, technical aspects of the America Invents Act, and administrative trials before the US Patent and Trademark Office, such as inter partes review.

While in law school, Nathan was a judicial extern for Chief Judge Randall R. Rader at the US Court of Appeals for the Federal Circuit. He is fluent in English, Portuguese, and Spanish.

• Counsel for patent owner WobbleWorks, which resulted in denial of institution of IPR in the Patent Trial and Appeal Board (Ditec Solutions, LLC et al v. WobbleWorks, Inc., IPR2018-01414)
• Represented pharmaceutical client in IP due diligence of various medical device and pharmaceutical technologies
• Led victorious global prosecution and enforcement efforts, across several countries, for a consumer products client
• Defended IP due diligence on behalf of AqueSys, Inc., in connection with its acquisition by Allergan plc for a $300 million upfront payment and regulatory approval and commercialization milestone payments
• Defended IP due diligence on behalf of a medical device client in connection with its successful $85 million initial public offering outside the United States
• Defended IP due diligence on behalf of AqueSys, Inc., in a $43.6 million Series D financing led by an undisclosed investor, with participation from Accuitive Medical Ventures, The Carlyle Group, Longitude Capital, Rho Ventures, and SV Life Sciences
• Defended IP due diligence on behalf of ArtVentive Medical Group, Inc., in a $5 million financing led by an undisclosed investor
• Represented a medical device client in the acquisition of another medical device company for more than $70 million
• Represented a medical device client in the acquisition of a cardiovascular medical device company
• Represented a medical device client in IP due diligence of a target cardiovascular device company